ANI Pharmaceuticals (NASDAQ:ANIP) is preparing to release its quarterly earnings on Friday, 2026-02-27. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect ANI Pharmaceuticals to report an earnings per share (EPS) of $1.83.
ANI Pharmaceuticals bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings History Snapshot
Last quarter the company beat EPS by $0.43, which was followed by a 0.0% drop in the share price the next day.
Here’s a look at ANI Pharmaceuticals’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 1.61 | 1.26 | -0.06 | 0.29 |
| EPS Actual | 2.04 | 1.80 | 1.70 | 1.63 |
| Price Change % | 0.22 | 18.07 | -7.31 | 13.39 |
Tracking ANI Pharmaceuticals’s Stock Performance
Shares of ANI Pharmaceuticals were trading at $76.3 as of February 25. Over the last …